KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Other Non-Current Assets (2019 - 2025)

GoodRx Holdings' Other Non-Current Assets history spans 7 years, with the latest figure at $29.1 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 23.7% year-over-year to $29.1 million; the TTM value through Dec 2025 reached $29.1 million, up 23.7%, while the annual FY2025 figure was $29.1 million, 23.7% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $29.1 million at GoodRx Holdings, up from $23.3 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $44.5 million in Q2 2023 and bottomed at $2.2 million in Q1 2021.
  • The 5-year median for Other Non-Current Assets is $26.6 million (2022), against an average of $26.1 million.
  • The largest annual shift saw Other Non-Current Assets skyrocketed 1603.9% in 2022 before it tumbled 37.92% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $6.0 million in 2021, then surged by 352.22% to $27.2 million in 2022, then soared by 39.06% to $37.8 million in 2023, then tumbled by 37.74% to $23.5 million in 2024, then increased by 23.7% to $29.1 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Other Non-Current Assets are $29.1 million (Q4 2025), $23.3 million (Q3 2025), and $23.9 million (Q2 2025).